Patents by Inventor Ammen P. Dhillon

Ammen P. Dhillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for silencing hepatitis B virus gene expression
    Patent number: 10415037
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target Hepatitis B virus (HBV) gene expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating HBV infection and/or HDV infection in humans).
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: September 17, 2019
    Assignee: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Jennifer L. Cross, Ammen P. Dhillon, Amy C. H. Lee, Ian MacLachlan, Nicholas M. Snead, Emily P. Thi
  • COMPOSITIONS AND METHODS FOR SILENCING HEPATITIS B VIRUS GENE EXPRESSION
    Publication number: 20180016583
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target Hepatitis B virus (HBV) gene expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating HBV infection and/or HDV infection in humans).
    Type: Application
    Filed: October 1, 2015
    Publication date: January 18, 2018
    Applicant: PROTIVA BIOTHERAPEUTICS, INC.
    Inventors: Jennifer L. CROSS, Ammen P. DHILLON, Amy C. H. LEE, Ian MACLACHLAN, Nicholas M. SNEAD, Emily P. THI
  • Compositions and methods for silencing SMAD4
    Patent number: 9035039
    Abstract: The present invention provides compositions comprising therapeutic nucleic acids such as interfering RNA (e.g., dsRNA such as siRNA) that target SMAD4 gene expression, lipid particles comprising one or more (e.g., a cocktail) of the therapeutic nucleic acids, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles (e.g., for treating anemia of inflammation in humans).
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: May 19, 2015
    Assignee: Protiva Biotherapeutics, Inc.
    Inventors: Ammen P. Dhillon, Amy C. H. Lee, Ian MacLachlan